Profound Medical Corp. Files 6-K, Reports Press Release
Ticker: PROF · Form: 6-K · Filed: Sep 16, 2024 · CIK: 1628808
| Field | Detail |
|---|---|
| Company | Profound Medical Corp. (PROF) |
| Form Type | 6-K |
| Filed Date | Sep 16, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, sec-filing
TL;DR
Profound Medical Corp. filed a 6-K on 9/16/24, including a press release. Standard reporting.
AI Summary
Profound Medical Corp. filed a Form 6-K on September 16, 2024, to report a press release dated September 16, 2024. The filing indicates the company is a foreign private issuer and will file its annual reports under cover of Form 40-F.
Why It Matters
This filing signals ongoing reporting activity and compliance for Profound Medical Corp. with the SEC, providing investors with updated information.
Risk Assessment
Risk Level: low — This is a routine filing reporting a press release and confirming filing status, with no new financial or operational disclosures that would inherently increase risk.
Key Players & Entities
- Profound Medical Corp. (company) — Registrant
- September 16, 2024 (date) — Press Release Date
- Form 6-K (document) — Filing Type
- Form 40-F (document) — Annual Report Cover
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report a press release dated September 16, 2024, as an exhibit.
What is the filing date of this Form 6-K?
The filing date of this Form 6-K is September 16, 2024.
Which form does Profound Medical Corp. indicate it will use for its annual reports?
Profound Medical Corp. indicates it will file its annual reports under cover of Form 40-F.
What is the principal executive office address of Profound Medical Corp.?
The principal executive office address is 2400 Skymark Avenue, Unit 6, Mississauga, Ontario L4W 5K5.
What is the Commission File Number for Profound Medical Corp.?
The Commission File Number for Profound Medical Corp. is 001-39032.
Filing Stats: 165 words · 1 min read · ~1 pages · Grade level 12.9 · Accepted 2024-09-16 08:15:04
Filing Documents
- f6k_091624.htm (6-K) — 5KB
- exh_991.htm (EX-99.1) — 13KB
- 0001171843-24-005197.txt ( ) — 19KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. PROFOUND MEDICAL CORP. (Registrant) Date: September 16, 2024 /s/ Rashed Dewan Rashed Dewan Chief Financial Officer